4.0 Article

Diabetes, Glucose Control, and 9-Year Cognitive Decline Among Older Adults Without Dementia

Journal

ARCHIVES OF NEUROLOGY
Volume 69, Issue 9, Pages 1170-1175

Publisher

AMER MEDICAL ASSOC
DOI: 10.1001/archneurol.2012.1117

Keywords

-

Funding

  1. NIH (NIA, National Institute of Diabetes and Digestive and Kidney Diseases, and National Institute of Mental Health)
  2. Department of Defense
  3. American Health Assistance Foundation
  4. Anonymous Foundation
  5. Alzheimer's Association
  6. Amgen
  7. Merck Serono
  8. GlaxoSmithKline
  9. NIH (National Institute of Diabetes and Digestive and Kidney Diseases and NIA)
  10. NIH/NIA
  11. NIH/NIA Intramural Research Program
  12. NIH
  13. NIA [N01-AG-6-2101, N01-AG-6-2103, N01-AG-6-2106, R01-AG028050]
  14. National Institute of Nursing Research [R01-NR012459]
  15. Intramural Research Program of the NIH, NIA
  16. American Health Assistance Foundation [A201-0029]

Ask authors/readers for more resources

Objectives: To determine if prevalent and incident diabetes mellitus (DM) increase risk of cognitive decline and if, among elderly adults with DM, poor glucose control is related to worse cognitive performance. Design: Prospective cohort study. Setting: Health, Aging, and Body Composition Study at 2 community clinics. Participants: A total of 3069 elderly adults (mean age, 74.2 years; 42% black; 52% female). Main Outcome Measures: Participants completed the Modified Mini-Mental State Examination (3MS) and Digit Symbol Substitution Test (DSST) at baseline and selected intervals over 10 years. Diabetes mellitus status was determined at baseline and during follow-up visits. Glycosylated hemoglobin A(1c) level was measured at years 1 (baseline), 4, 6, and 10 from fasting whole blood. Results: At baseline, 717 participants (23.4%) had prevalent DM and 2352 (76.6%) were without DM, 159 of whom developed incidentDMduring follow-up. Participants with prevalent DM had lower baseline test scores than participants without DM(3MS: 88.8 vs 90.9; DSST: 32.5 vs 36.3, respectively; t = 6.09; P =. 001 for both tests). Results from mixed-effects models showed a similar pattern for 9-year decline (3MS: -6.0-vs -4.5-point decline; t = 2.66; P =. 008; DSST: -7.9-vs -5.7-point decline; t = 3.69; P =. 001, respectively). Participants with incident DM tended to have baseline and 9-year decline scores between the other 2 groups but were not statistically different from the group without DM. Multivariate adjustment for demographics and medical comorbidities produced similar results. Among participants with prevalent DM, glycosylated hemoglobin A1c level was associated with lower average mean cognitive scores (3MS: F = 8.2; P for overall =. 003; DSST: F = 3.4; P for overall =. 04), even after multivariate adjustment. Conclusion: Among well-functioning older adults, DM and poor glucose control among those with DM are associated with worse cognitive function and greater decline. This suggests that severity of DM may contribute to accelerated cognitive aging. Arch Neurol. 2012; 69(9): 1170-1175. Published online June 18, 2012. doi: 10.1001/archneurol.2012.1117

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available